<DOC>
	<DOCNO>NCT00114023</DOCNO>
	<brief_summary>This 1-year follow-up study evaluate long-term effect subject completely clear actinic keratosis ( AK ) lesions 1473-IMIQ study . The 1473-IMIQ study evaluate safety effectiveness imiquimod 5 % cream compare placebo cream treatment AK .</brief_summary>
	<brief_title>1-Year Follow 1473-IMIQ Study</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Subject participate 1473IMIQ Study AND 100 % clearance AK lesion Did use topical preparation previous treatment area within 24hours scheduled visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>AK</keyword>
	<keyword>Imiquimod 5 % cream</keyword>
	<keyword>3M Pharmaceuticals</keyword>
	<keyword>Aldara</keyword>
	<keyword>Actinic Keratosis</keyword>
</DOC>